About Maria Nichol
Maria Nichol is a chief business officer at Artax Biopharma.
Maria Nichol first appears on SEC filings in 2024.
Experience
This experience comes from Maria Nichol's profile and from SEC filings. For roles taken from filings, the years are when the filings name Maria Nichol in the role, so the role may have started earlier or lasted longer.
TR
Transmucosis Current
Corporate Development & IP
2025 – Present
Artax Biopharma, Inc. Current
Chief Business Officer
2023 – Present · Cambridge, MA
Develops oral drug candidates for people with autoimmune diseases.
CL
Compass IP Limited Current
Consultant and Managing Director
2022 – Present
AT
Agomab Therapeutics Current
Head of IP
2022 – Present
GA
Galapagos
Consultant - IP, BD
2006 – 2023
FT
Fibrocor Therapeutics
Non Executive Board Member
2021
KL
K2 IP Ltd
K2 Network Attorney
2016 – 2017
BL
Biotica Technology Limited
IP Manager
2003 – 2006
OG
Oxford Glycosciences
Patent Associate
2003 – 2005
Key Colleagues at Startups
The people Maria Nichol works with at each company, as listed on that company's latest Form D.
Artax Biopharma, Inc. · Form D/A, May 5, 2026
Joe Suarez
Chief Financial Officer
Andre Hoekema
Board Chair
AW
Alan Walts
Director
DD
Damia Tormo, Ph.D.
Director
GS
Gino Santini
Director
Casper Breum
Director
RP
Raj Parekh
Director
Robert Armstrong, Ph.D.
Chief Executive Officer and director